Teratology

Last updated

Teratology is the study of abnormalities of physiological development in organisms during their life span. It is a sub-discipline in medical genetics which focuses on the classification of congenital abnormalities in dysmorphology caused by teratogens. Teratogens are substances that may cause non-heritable birth defects via a toxic effect on an embryo or fetus. [1] Defects include malformations, disruptions, deformations, and dysplasia that may cause stunted growth, delayed mental development, or other congenital disorders that lack structural malformations. [2] The related term developmental toxicity includes all manifestations of abnormal development that are caused by environmental insult. [3] The extent to which teratogens will impact an embryo is dependent on several factors, such as how long the embryo has been exposed, the stage of development the embryo was in when exposed, the genetic makeup of the embryo, and the transfer rate of the teratogen. [4]

Contents

Etymology

The term was borrowed in 1842 from the French tératologie, where it was formed in 1830 from the Greek τέραςteras (word stem τέρατ-terat-), meaning "sign sent by the gods, portent, marvel, monster", and -ologie ( -ology ), used to designate a discourse, treaty, science, theory, or study of some topic. [5]

Old literature referred to abnormalities of all kinds under the Latin term Lusus naturae (lit. "freak of nature"). As early as the 17th century, Teratology referred to a discourse on prodigies and marvels of anything so extraordinary as to seem abnormal. In the 19th century, it acquired a meaning more closely related to biological deformities, mostly in the field of botany. Currently, its most instrumental meaning is that of the medical study of teratogenesis, congenital malformations or individuals with significant malformations. Historically, people have used many pejorative terms to describe/label cases of significant physical malformations. In the 1960s, David W. Smith of the University of Washington Medical School (one of the researchers who became known in 1973 for the discovery of fetal alcohol syndrome), [6] popularized the term teratology. With the growth of understanding of the origins of birth defects, the field of teratology as of 2015 overlaps with other fields of science, including developmental biology, embryology, and genetics.

Until the 1940s, teratologists regarded birth defects as primarily hereditary. In 1941, the first well-documented cases of environmental agents being the cause of severe birth defects were reported. [7]

Teratogenesis

Wilson's principles

In 1959 and in his 1973 monograph Environment and Birth Defects, embryologist James Wilson put forth six principles of teratogenesis to guide the study and understanding of teratogenic agents and their effects on developing organisms. [8] These principles were derived from and expanded on by those laid forth by zoologist Camille Dareste in the late 1800s: [8] [9]

  1. Susceptibility to teratogenesis depends on the genotype of the conceptus and the manner in which this interacts with adverse environmental factors.
  2. Susceptibility to teratogenesis varies with the developmental stage at the time of exposure to an adverse influence. There are critical periods of susceptibility to agents and organ systems affected by these agents.
  3. Teratogenic agents act in specific ways on developing cells and tissues to initiate sequences of abnormal developmental events.
  4. The access of adverse influences to developing tissues depends on the nature of the influence. Several factors affect the ability of a teratogen to contact a developing conceptus, such as the nature of the agent itself, route and degree of maternal exposure, rate of placental transfer and systemic absorption, and composition of the maternal and embryonic/fetal genotypes.
  5. There are four manifestations of deviant development (death, malformation, growth retardation and functional defect).
  6. Manifestations of deviant development increase in frequency and degree as dosage increases from the No Observable Adverse Effect Level (NOAEL) to a dose producing 100% lethality (LD100).

Research

Studies designed to test the teratogenic potential of environmental agents use animal model systems (e.g., rat, mouse, rabbit, dog, and monkey). Early teratologists exposed pregnant animals to environmental agents and observed the fetuses for gross visceral and skeletal abnormalities. While this is still part of the teratological evaluation procedures today, the field of Teratology is moving to a more molecular level, seeking the mechanism(s) of action by which these agents act. One example of this is the use of mammalian animal models to evaluate the molecular role of teratogens in the development of embryonic populations, such as the neural crest, [10] which can lead to the development of neurocristopathies. Genetically modified mice are commonly used for this purpose. In addition, pregnancy registries are large, prospective studies that monitor exposures women receive during their pregnancies and record the outcome of their births. These studies provide information about possible risks of medications or other exposures in human pregnancies. Prenatal alcohol exposure (PAE) can produce craniofacial malformations, a phenotype that is visible in Fetal Alcohol Syndrome. Current evidence suggests that craniofacial malformations occur via: apoptosis of neural crest cells, [11] interference with neural crest cell migration, [12] [13] as well as the disruption of sonic hedgehog (shh) signaling. [14]

Understanding how a teratogen causes its effect is not only important in preventing congenital abnormalities but also has the potential for developing new therapeutic drugs safe for use with pregnant women.

Causes

Common causes of teratogenesis include: [15] [16]

Human pregnancy

In humans, congenital disorders resulted in about 510,000 deaths globally in 2010. [23]

About 3% of newborns have a "major physical anomaly", meaning a physical anomaly that has cosmetic or functional significance. [24] Congenital disorders are responsible for 20% of infant deaths. [25] The most common congenital diseases are heart defects, Down syndrome, and neural tube defects. Trisomy 21 is the most common type of Down Syndrome. About 95% of infants born with Down Syndrome have this disorder and it consists of 3 separate copies of chromosomes. Translocation Down syndrome is not as common, as only 3% of infants with Down Syndrome are diagnosed with this type. [26] VSD, ventricular septal defect, is the most common type of heart defect in infants. If an infant has a large VSD it can result into heart failure. [27] Infants with a smaller VSD have a 96% survival rate and those with a moderate VSD have about an 86% survival rate.[ citation needed ] Lastly, NTD, neural tube defect, is a defect that forms in the brain and spine during early development. If the spinal cord is exposed and touching the skin it can require surgery to prevent an infection. [28]

Medicines

Acitretin

Acitretin is highly teratogenic and noted for the possibility of severe birth defects. It should not be used by pregnant women or women planning to get pregnant within 3 years following the use of acitretin. Sexually active women of childbearing age who use acitretin should also use at least two forms of birth control concurrently. Men and women who use it should not donate blood for three years after using it, because of the possibility that the blood might be used in a pregnant patient and cause birth defects. In addition, it may cause nausea, headache, itching, dry, red or flaky skin, dry or red eyes, dry or chapped lips, swollen lips, dry mouth, thirst, cystic acne or hair loss. [29] [30] [31] ]]

Etretinate

Etretinate (trade name Tegison) is a medication developed by Hoffmann–La Roche that was approved by the FDA in 1986 to treat severe psoriasis. It is a second-generation retinoid. [32] It was subsequently removed from the Canadian market in 1996 and the United States market in 1998 due to the high risk of birth defects. It remains on the market in Japan as Tigason.

Vaccination

In humans, vaccination has become readily available, and is important for the prevention of various communicable diseases such as polio and rubella, among others. There has been no association between congenital malformations and vaccination — for example, a population-wide study in Finland in which expectant mothers received the oral polio vaccine found no difference in infant outcomes when compared with mothers from reference cohorts who had not received the vaccine. [33] However, on grounds of theoretical risk, it is still not recommended to vaccinate for polio while pregnant unless there is risk of infection. [34] An important exception to this relates to provision of the influenza vaccine while pregnant. During the 1918 and 1957 influenza pandemics, mortality from influenza in pregnant women was 45%. In a 2005 study of vaccination during pregnancy, Munoz et al. demonstrated that there was no adverse outcome observed in the new infants or mothers, suggesting that the balance of risk between infection and vaccination favored preventative vaccination. [35]

Reproductive hormones and hormone replacement therapy

There are a number of ways that a fetus can be affected in pregnancy, specifically due to exposure to various substances. There are a number of drugs that can do this, specifically drugs such as female reproductive hormones or hormone replacement drugs such as estrogen and progesterone that are not only essential for reproductive health, but also pose concerns when it comes to the synthetic alternatives to these. This can cause a multitude of congenital abnormalities and deformities, many of which can ultimately affect the fetus and even the mother's reproductive system in the long term. According to a study conducted from 2015 till 2018, it was found that there was an increased risk of both maternal and neonatal complications developing as a result of hormone replacement therapy cycles being conducted during pregnancy, especially in regards to hormones such as estrogen, testosterone and thyroid hormone. [36] [37] [38] When hormones such as estrogen and testosterone are replaced, this can cause the fetus to become stunted in growth, born prematurely with a lower birth weight, develop mental retardation, while in turn causing the mother's ovarian reserve to be depleted while increasing ovarian follicular recruitment. [39]

Withdrawn drugs

Thalidomide
Thalidomide chemical structure. The chemical structure of thalidomide allows it to act as a DNA intercalating agent. Thalidomide-2D-skeletal.png
Thalidomide chemical structure. The chemical structure of thalidomide allows it to act as a DNA intercalating agent.

Thalidomide was once prescribed therapeutically from the 1950s to early 1960s in Europe as an anti-nausea medication to alleviate morning sickness among pregnant women. While the exact mechanism of action of thalidomide is not known, it is thought to be related to inhibition of angiogenesis through interaction with the insulin like growth factor(IGF-1) and fibroblast like growth factor 2 (FGF-2) pathways. [40] In the 1960s, it became apparent that thalidomide altered embryo development and led to limb deformities such as thumb absence, underdevelopment of entire limbs, or phocomelia. [40] Thalidomide may have caused teratogenic effects in over 10,000 babies worldwide. [41] [42]

Recreational drugs

Alcohol

Baby with fetal alcohol syndrome, showing some of the characteristic facial features. Photo of baby with FAS.jpg
Baby with fetal alcohol syndrome, showing some of the characteristic facial features.

In the US, alcohol is subject to the FDA drug labeling Pregnancy Category X (Contraindicated in pregnancy). Alcohol is known to cause fetal alcohol spectrum disorder.

There are a wide range of affects that Prenatal Alcohol Exposure (PAE) can have on a developing fetus. Some of the most prominent possible outcomes include the development of Fetal Alcohol Syndrome, a reduction in brain volume, still births, spontaneous abortions, impairments of the nervous system, and much more. [43] Fetal Alcohol Syndrome has numerous symptoms which may include cognitive impairments and impairment of the facial features. [43] PAE remains the leading cause of birth defects and neurodevelopmental abnormalities in the United States, affecting 9.1 to 50 per 1000 live births in the U.S. and 68.0 to 89.2 per 1000 in populations with high levels of alcohol use. [44]

Tobacco

Consuming tobacco products while pregnant or breastfeeding can have significant negative impacts on the health and development of the unborn child and newborn infant. [45]

Lead exposure during pregnancy

Long before modern science, it was understood that heavy metals could cause negative effects to those who were exposed. The Greek physician Pedanius Dioscorides described the effects of lead exposure as something that "makes the mind give way." Lead exposure in adults can lead to cardiological, renal, reproductive, and cognitive issues that are often irreversible, however, lead exposure during pregnancy can be detrimental to the long-term health of the fetus. [46] Exposure to lead during pregnancy is well known to have teratogenic effects on the development of a fetus. [47] Specifically, fetal exposure to lead can cause cognitive impairment, premature births, unplanned abortions, ADHD, and much more. [48] Lead exposure during the first trimester of pregnancy leads to the greatest predictability of cognitive development issues after birth. [49]

Low socioeconomic status correlates to a higher probability of lead exposure. [50] A well-known recent example of lead poisoning - and the impacts it can have on a community - was the 2014 water crisis in Flint, Michigan. Researchers have found that female fetuses developed at a higher rate than male fetuses in Flint when compared to surrounding areas. The higher rate of female births indicated a problem because male fetuses are more sensitive to pregnancy hazards than female fetuses. [51]

Other animals

Fossil record

Evidence for congenital deformities found in the fossil record is studied by paleopathologists, specialists in ancient disease and injury. Fossils bearing evidence of congenital deformity are scientifically significant because they can help scientists infer the evolutionary history of life's developmental processes. For instance, because a Tyrannosaurus rex specimen has been discovered with a block vertebra, it means that vertebrae have been developing the same basic way since at least the most recent common ancestor of dinosaurs and mammals. Other notable fossil deformities include a hatchling specimen of the bird-like dinosaur, Troodon , the tip of whose jaw was twisted. [52] Another notably deformed fossil was a specimen of the Choristodera Hyphalosaurus , which had two heads- the oldest known example of polycephaly. [53]

Thalidomide and chick limb development

Thalidomide is a teratogen known to be significantly detrimental to organ and limb development during embryogenesis. [54] It has been observed in chick embryos that exposure to thalidomide can induce limb outgrowth deformities, due to increased oxidative stress interfering with the Wnt signaling pathway, increasing apoptosis, and damaging immature blood vessels in developing limb buds. [18] [55]

Retinoic acid and mouse limb development

Retinoic acid (RA) is significant in embryonic development. It induces the function of limb patterning of a developing embryo in species such as mice and other vertebrate limbs. [56] For example, during the process of regenerating a newt limb an increased amount of RA moves the limb more proximal to the distal blastoma and the extent of the proximalization of the limb increases with the amount of RA present during the regeneration process. [56] A study looked at the RA activity intracellularly in mice in relation to human regulating CYP26 enzymes which play a critical role in metabolizing RA. [56] This study also helps to reveal that RA is significant in various aspects of limb development in an embryo, however irregular control or excess amounts of RA can have teratogenic impacts causing malformations of limb development. They looked specifically at CYP26B1 which is highly expressed in regions of limb development in mice. [56] The lack of CYP26B1 was shown to cause a spread of RA signal towards the distal section of the limb causing proximo-distal patterning irregularities of the limb. [56] Not only did it show spreading of RA but a deficiency in the CYP26B1 also showed an induced apoptosis effect in the developing mouse limb but delayed chondrocyte maturation, which are cells that secrete a cartilage matrix which is significant for limb structure. [56] They also looked at what happened to development of the limbs in wild type mice, that are mice with no CYP26B1 deficiencies, but which had an excess amount of RA present in the embryo. The results showed a similar impact to limb patterning if the mice did have the CYP26B1 deficiency meaning that there was still a proximal distal patterning deficiency observed when excess RA was present. [56] This then concludes that RA plays the role of a morphogen to identify proximal distal patterning of limb development in mice embryos and that CYP26B1 is significant to prevent apoptosis of those limb tissues to further proper development of mice limbs in vivo.

Rat development and lead exposure

There has been evidence of teratogenic effects of lead in rats as well. An experiment was conducted where pregnant rats were given drinking water, before and during pregnancy, that contained lead. Many detrimental effects, and signs of teratogenesis were found, such as negative impacts on the formation of the cerebellum, fetal mortality, and developmental issues for various parts of the body. [57]

Plants

In botany, teratology investigates the theoretical implications of abnormal specimens. For example, the discovery of abnormal flowers—for example, flowers with leaves instead of petals, or flowers with staminoid pistils—furnished important evidence for the "foliar theory", the theory that all flower parts are highly specialised leaves. [58] In plants, such specimens are denoted as 'lusus naturae' ('sports of nature', abbreviated as 'lus.'); and occasionally as 'ter.', 'monst.', or 'monstr.'. [59]

Types of deformations in plants

Plants can have mutations that leads to different types of deformations such as:

See also

Related Research Articles

<span class="mw-page-title-main">Phocomelia</span> Medical condition

Phocomelia is a congenital condition that involves malformations of human arms and legs which results in a flipper-like appendage. A prominent cause of phocomelia is the mother's use of the drug thalidomide during pregnancy; however, the causes of most cases are to be determined.

Morning sickness, also called nausea and vomiting of pregnancy (NVP), is a symptom of pregnancy that involves nausea or vomiting. Despite the name, nausea or vomiting can occur at any time during the day. Typically the symptoms occur between the 4th and 16th week of pregnancy. About 10% of women still have symptoms after the 20th week of pregnancy. A severe form of the condition is known as hyperemesis gravidarum and results in weight loss.

<span class="mw-page-title-main">Birth defect</span> Condition present at birth regardless of cause

A birth defect, also known as a congenital disorder, is an abnormal condition that is present at birth regardless of its cause. Birth defects may result in disabilities that may be physical, intellectual, or developmental. The disabilities can range from mild to severe. Birth defects are divided into two main types: structural disorders in which problems are seen with the shape of a body part and functional disorders in which problems exist with how a body part works. Functional disorders include metabolic and degenerative disorders. Some birth defects include both structural and functional disorders.

<span class="mw-page-title-main">Deformity</span> Physical abnormality in a living organism

A deformity, dysmorphism, or dysmorphic feature is a major abnormality of an organism that makes a part of the body appear or function differently than how it is supposed to.

<span class="mw-page-title-main">Fetal alcohol spectrum disorder</span> Group of conditions resulting from maternal alcohol consumption during pregnancy

Fetal alcohol spectrum disorders (FASDs) are a group of conditions that can occur in a person who is exposed to alcohol during gestation, as a result of their mother drinking alcohol during pregnancy. The several forms of the condition are: fetal alcohol syndrome (FAS), partial fetal alcohol syndrome (pFAS), alcohol-related neurodevelopmental disorder (ARND), and neurobehavioral disorder associated with prenatal alcohol exposure (ND-PAE). Other terms used are fetal alcohol effects (FAE), partial fetal alcohol effects (PFAE), alcohol-related birth defects (ARBD), and static encephalopathy, but these terms have fallen out of favor and are no longer considered part of the spectrum.

James G. Wilson (1915–1987) was an embryologist and anatomist, known for his Six Principles of Teratology. In 1960 he co-founded The Teratology Society, and was since then one of its most active members.

Environmental toxicants and fetal development is the impact of different toxic substances from the environment on the development of the fetus. This article deals with potential adverse effects of environmental toxicants on the prenatal development of both the embryo or fetus, as well as pregnancy complications. The human embryo or fetus is relatively susceptible to impact from adverse conditions within the mother's environment. Substandard fetal conditions often cause various degrees of developmental delays, both physical and mental, for the growing baby. Although some variables do occur as a result of genetic conditions pertaining to the father, a great many are directly brought about from environmental toxins that the mother is exposed to.

Prenatal development includes the development of the embryo and of the fetus during a viviparous animal's gestation. Prenatal development starts with fertilization, in the germinal stage of embryonic development, and continues in fetal development until birth.

Maternal use of androgens or high doses of certain weakly androgenic synthetic progestogens (progestins) structurally related to testosterone can masculinize (virilize) the vulva of a female fetus during susceptible times in pregnancy.

<span class="mw-page-title-main">Fetal surgery</span> Growing branch of maternal-fetal medicine

Fetal surgery also known as antenatal surgery, prenatal surgery, is a growing branch of maternal-fetal medicine that covers any of a broad range of surgical techniques that are used to treat congenital abnormalities in fetuses who are still in the pregnant uterus. There are three main types: open fetal surgery, which involves completely opening the uterus to operate on the fetus; minimally invasive fetoscopic surgery, which uses small incisions and is guided by fetoscopy and sonography; and percutaneous fetal therapy, which involves placing a catheter under continuous ultrasound guidance.

<span class="mw-page-title-main">Fetal warfarin syndrome</span> Congenital disorder caused by maternal warfarin administration

Fetal warfarin syndrome is a disorder of the embryo which occurs in a child whose mother took the medication warfarin during pregnancy. Resulting abnormalities include low birth weight, slower growth, intellectual disability, deafness, small head size, and malformed bones, cartilage, and joints.

Congenital amputation is birth without a limb or limbs, or without a part of a limb or limbs.

N-Nitroso-N-methylurea (NMU) is a highly reliable carcinogen, mutagen, and teratogen. NMU is an alkylating agent, and exhibits its toxicity by transferring its methyl group to nucleobases in nucleic acids, which can lead to AT:GC transition mutations.

Women should speak to their doctor or healthcare professional before starting or stopping any medications while pregnant. Non-essential drugs and medications should be avoided while pregnant. Tobacco, alcohol, marijuana, and illicit drug use while pregnant may be dangerous for the unborn baby and may lead to severe health problems and/or birth defects. Even small amounts of alcohol, tobacco, and marijuana have not been proven to be safe when taken while pregnant. In some cases, for example, if the mother has epilepsy or diabetes, the risk of stopping a medication may be worse than risks associated with taking the medication while pregnant. The mother's healthcare professional will help make these decisions about the safest way to protect the health of both the mother and unborn child. In addition to medications and substances, some dietary supplements are important for a healthy pregnancy, however, others may cause harm to the unborn child.

<span class="mw-page-title-main">Thalidomide scandal</span> Medical condition

In the late 1950s and early 1960s, the use of thalidomide in 46 countries by women who were pregnant or who subsequently became pregnant resulted in the "biggest anthropogenic medical disaster ever," with more than 10,000 children born with a range of severe deformities, such as phocomelia, as well as thousands of miscarriages.

Prenatal cocaine exposure (PCE), theorized in the 1970s, occurs when a pregnant woman uses cocaine and thereby exposes her fetus to the drug. Babies whose mothers used cocaine while pregnant supposedly have increased risk of several different health issues during growth and development.

Prenatal memory, also called fetal memory, is important for the development of memory in humans. Many factors can impair fetal memory and its functions, primarily maternal actions. There are multiple techniques available not only to demonstrate the existence of fetal memory but to measure it. Fetal memory is vulnerable to certain diseases so much so that exposure can permanently damage the development of the fetus and even terminate the pregnancy by aborting the fetus. Maternal nutrition and the avoidance of drugs, alcohol and other substances during all nine months of pregnancy is important to the development of the fetus and its memory systems. The use of certain substances can entail long-term permanent effects on the fetus that can carry on throughout their lifespan.

<span class="mw-page-title-main">Developmental toxicity</span>

Developmental toxicity is any developmental malformation that is caused by the toxicity of a chemical or pathogen. It is the structural or functional alteration, reversible or irreversible, which interferes with homeostasis, normal growth, differentiation, development or behavior. Developmental toxicity is caused by environmental insult, which includes drugs, alcohol, diet, toxic chemicals, and physical factors.

Müllerian duct anomalies are those structural anomalies caused by errors in Müllerian duct development during embryonic morphogenesis. Factors that precipitate include genetics, and maternal exposure to teratogens.

<span class="mw-page-title-main">Diabetic embryopathy</span> Medical condition

Diabetic embryopathy refers to congenital maldevelopments that are linked to maternal diabetes. Prenatal exposure to hyperglycemia can result in spontaneous abortions, perinatal mortality, and malformations. Type 1 and Type 2 diabetic pregnancies both increase the risk of diabetes induced teratogenicity. The rate of congenital malformations is similar in Type 1 and 2 mothers because of increased adiposity and the age of women with type 2 diabetes. Genetic predisposition and different environmental factors both play a significant role in the development of diabetic embryopathy. Metabolic dysfunction in pregnant mothers also increases the risk of fetal malformations.

References

  1. ↑ Bastow BD, Holmes JL, Trupin SR, Draper JC, Matthews Jr KJ (23 February 2016). Talavera F (ed.). "Teratology and drug use during pregnancy". Medscape. WebMD. Retrieved 24 February 2016.
  2. ↑ Gilbert SF, Epel D (2015). Ecological developmental biology: the environmental regulation of development, health, and evolution (2nd ed.). Sunderland, MA: Sinauer Associates, Inc. Publishers.
  3. ↑ Rogers JM, Kavlock RJ (1996). "Developmental Toxicology". In Klaassen CD (ed.). Casarett and Doull's Toxicology : the basic science of poisons (5th ed.). New York: McGraw-Hill, Health Professions Division. pp. 301–331. ISBN   978-0-07-105476-8.
  4. ↑ Macnow AS, ed. (2022). MCAT biology review 2023–2024 : online + book (2023-2024 ed.). Fort Lauderdale, Florida: Kaplan Publishing. ISBN   978-1-5062-8295-4. OCLC   1334083218.
  5. ↑ "Teratology". Merriam-Webster Dictionary.
  6. ↑ Jones KL, Smith DW, Ulleland CN, Streissguth P (June 1973). "Pattern of malformation in offspring of chronic alcoholic mothers". Lancet. 1 (7815): 1267–1271. doi:10.1016/S0140-6736(73)91291-9. PMID   4126070.
  7. ↑ "Birth Defects". Howmed.net. 24 July 2011. Retrieved 1 November 2015. Until 1940, it was assumed that congenital defects were caused primarily by hereditary factors. In 1941, the first well-documented cases were reported that an environmental agent (rubella virus) could produce severe anatomic anomalies.
  8. 1 2 Wilson JG (1973). Environment and Birth Defects (Environmental Science Series). London: Academic Pr. ISBN   0-12-757750-5.
  9. ↑ "James G. Wilson's Six Principles of Teratology". The Embryo Project Encyclopedia. Retrieved 20 March 2023.
  10. ↑ Cerrizuela S, Vega-Lopez GA, Aybar MJ (May 2020). "The role of teratogens in neural crest development". Birth Defects Research. 112 (8): 584–632. doi:10.1002/bdr2.1644. PMID   31926062. S2CID   210151171.
  11. ↑ Sulik KK, Cook CS, Webster WS (1988). "Teratogens and craniofacial malformations: relationships to cell death". Development. 103 (Suppl): 213–231. doi:10.1242/dev.103.Supplement.213. PMID   3074910.
  12. ↑ Shi Y, Li J, Chen C, Gong M, Chen Y, Liu Y, et al. (September 2014). "5-Mehtyltetrahydrofolate rescues alcohol-induced neural crest cell migration abnormalities". Molecular Brain. 7 (67): 67. PMID   25223405.{{cite journal}}: CS1 maint: overridden setting (link)
  13. ↑ Cartwright MM, Smith SM (December 1995). "Stage-dependent effects of ethanol on cranial neural crest cell development: partial basis for the phenotypic variations observed in fetal alcohol syndrome". Alcoholism: Clinical and Experimental Research. 19 (6): 1454–1462. doi:10.1111/j.1530-0277.1995.tb01007.x. PMID   8749810.
  14. ↑ Boschen KE, Fish EW, Parnell SE (19 October 2019). "Prenatal alcohol exposure disrupts Shh pathway and primary cilia genes in the mouse neural tube". bioRxiv   10.1101/649673 .
  15. ↑ "Teratogens". The Embryo Project Encyclopedia. Retrieved 27 March 2023.
  16. 1 2 3 Gilbert-Barness E (20 March 2010). "Teratogenic causes of malformations". Annals of Clinical and Laboratory Science. 40 (2): 99–114. PMID   20421621.
  17. ↑ Welch-Carre E (August 2005). "The neurodevelopmental consequences of prenatal alcohol exposure". Advances in Neonatal Care. 5 (4). Medscape: 217–229. doi:10.1016/j.adnc.2005.04.007. PMID   16084479. S2CID   36424689.
  18. 1 2 Therapontos C, Erskine L, Gardner ER, Figg WD, Vargesson N (May 2009). "Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation". Proceedings of the National Academy of Sciences of the United States of America. 106 (21): 8573–8578. Bibcode:2009PNAS..106.8573T. doi: 10.1073/pnas.0901505106 . PMC   2688998 . PMID   19433787.
  19. ↑ Holt D, Webb M (April 1986). "The toxicity and teratogenicity of mercuric mercury in the pregnant rat". Archives of Toxicology. 58 (4): 243–248. doi:10.1007/BF00297114. PMID   3718227. S2CID   22045389.
  20. ↑ Bellinger DC (June 2005). "Teratogen update: lead and pregnancy". Birth Defects Research. Part A, Clinical and Molecular Teratology. 73 (6): 409–420. doi: 10.1002/bdra.20127 . PMID   15880700.
  21. ↑ Jacobson JL, Jacobson SW (May 1997). "Teratogen update: polychlorinated biphenyls". Teratology. 55 (5): 338–347. doi:10.1002/(SICI)1096-9926(199705)55:5<338::AID-TERA6>3.0.CO;2-V. PMID   9261928.
  22. ↑ Ziskin MC, Morrissey J (June 2011). "Thermal thresholds for teratogenicity, reproduction, and development". International Journal of Hyperthermia. 27 (4): 374–387. doi:10.3109/02656736.2011.553769. PMID   21591900.
  23. ↑ Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. (December 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010". Lancet. 380 (9859): 2095–2128. doi:10.1016/S0140-6736(12)61728-0. hdl: 10536/DRO/DU:30050819 . PMC   10790329 . PMID   23245604. S2CID   1541253.[ permanent dead link ]
  24. ↑ Abas AK, Fausto N, Kumar V (eds.). Robbins and Cotran's Pathologic Basis of Disease (7th ed.). p. 470. ISBN   978-0-7216-0187-8.
  25. ↑ CDC (21 December 2022). "Data & Statistics on Birth Defects | CDC". Centers for Disease Control and Prevention. Retrieved 5 February 2023.
  26. ↑ CDC (18 November 2022). "Facts about Down Syndrome | CDC". Centers for Disease Control and Prevention. Retrieved 5 April 2023.
  27. ↑ "Ventricular Septal Defect (VSD) (for Parents) – Nemours KidsHealth". kidshealth.org. Retrieved 5 April 2023.
  28. ↑ "Neural Tube Defects". www.hopkinsmedicine.org. 8 August 2021. Retrieved 5 April 2023.
  29. ↑ "Soriatane". WebMD . Retrieved 15 August 2015.
  30. ↑ "Soriatane Side Effects". Drugs.com . Retrieved 15 August 2015.
  31. ↑ "Soriatane (Acitretin) Drug Information: Description, User Reviews, Drug Side Effects, Interactions - Prescribing Information at RxList". RxList . Archived from the original on 2 December 2013. Retrieved 15 August 2015.
  32. ↑ Mutschler E, Schäfer-Korting M (2001). Arzneimittelwirkungen (in German) (8 ed.). Stuttgart: Wissenschaftliche Verlagsgesellschaft. p. 728f. ISBN   3-8047-1763-2.
  33. ↑ Harjulehto-Mervaala T, Aro T, Hiilesmaa VK, Saxén H, Hovi T, Saxén L (September 1993). "Oral polio vaccination during pregnancy: no increase in the occurrence of congenital malformations". American Journal of Epidemiology. 138 (6): 407–414. doi:10.1093/oxfordjournals.aje.a116873. PMID   8213746.
  34. ↑ "Guidelines for Vaccinating Pregnant Women". cdc.gov. Centers for Disease Control and Prevention: Advisory Committee on Immunization Practices (ACIP). 13 January 2021. Although no adverse effects of IPV have been documented among pregnant women or their fetuses, vaccination of pregnant women should be avoided on theoretical grounds. However, if a pregnant woman is at increased risk for infection and requires immediate protection against polio, IPV can be administered in accordance with the recommended schedules for adults.
  35. ↑ Munoz FM, Greisinger AJ, Wehmanen OA, Mouzoon ME, Hoyle JC, Smith FA, et al. (April 2005). "Safety of influenza vaccination during pregnancy". American Journal of Obstetrics and Gynecology. 192 (4): 1098–1106. doi:10.1016/j.ajog.2004.12.019. PMID   15846187.
  36. ↑ Zong L, Liu P, Zhou L, Wei D, Ding L, Qin Y (May 2020). "Increased risk of maternal and neonatal complications in hormone replacement therapy cycles in frozen embryo transfer". Reproductive Biology and Endocrinology. 18 (1): 36. doi: 10.1186/s12958-020-00601-3 . PMC   7199365 . PMID   32366332.
  37. ↑ van den Broek S, Lupattelli A, Frank AS, Haug LS, Nordeng H (June 2021). "Thyroid hormone replacement therapy in pregnancy and motor function, communication skills, and behavior of preschool children: The Norwegian Mother, Father, and Child Cohort Study". Pharmacoepidemiology and Drug Safety. 30 (6): 716–726. doi:10.1002/pds.5184. PMC   8247290 . PMID   33314561.
  38. ↑ Steckler T, Wang J, Bartol FF, Roy SK, Padmanabhan V (July 2005). "Fetal programming: prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increases ovarian follicular recruitment". Endocrinology. 146 (7): 3185–93. doi:10.1210/en.2004-1444. PMID   15802500.
  39. ↑ Knox RV (August 2005). "Recruitment and selection of ovarian follicles for determination of ovulation rate in the pig". Domestic Animal Endocrinology. 29 (2): 385–97. doi:10.1016/j.domaniend.2005.02.025. PMID   15998504.
  40. 1 2 3 Stephens TD, Bunde CJ, Fillmore BJ (June 2000). "Mechanism of action in thalidomide teratogenesis". Biochemical Pharmacology. 59 (12): 1489–1499. doi:10.1016/S0006-2952(99)00388-3. PMID   10799645.
  41. ↑ Kim JH, Scialli AR (July 2011). "Thalidomide: the tragedy of birth defects and the effective treatment of disease". Toxicological Sciences. 122 (1): 1–6. doi: 10.1093/toxsci/kfr088 . PMID   21507989.
  42. ↑ Martínez-Frías ML (June 2012). "[The thalidomide experience: review of its effects 50 years later]". Medicina Clinica (in Spanish). 139 (1): 25–32. doi:10.1016/j.medcli.2011.10.011. PMID   22177324.
  43. 1 2 Popova S, Dozet D, Shield K, Rehm J, Burd L (September 2021). "Alcohol's Impact on the Fetus". Nutrients. 13 (10): 3452. doi: 10.3390/nu13103452 . PMC   8541151 . PMID   34684453.
  44. ↑ Gordis E. "Fetal Alcohol Exposure and the Brain". National Institute on Alcohol Abuse and Alcoholism.
  45. ↑ Haustein KO (September 1999). "Cigarette smoking, nicotine and pregnancy". International Journal of Clinical Pharmacology and Therapeutics. 37 (9): 417–427. PMID   10507240.
  46. ↑ Kasten-Jolly J, Lawrence DA (November 2017). "Sex-specific effects of developmental lead exposure on the immune-neuroendocrine network". Toxicology and Applied Pharmacology. 334: 142–157. doi:10.1016/j.taap.2017.09.009. PMID   28911972.
  47. ↑ Hu H, Téllez-Rojo MM, Bellinger D, Smith D, Ettinger AS, Lamadrid-Figueroa H, et al. (November 2006). "Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development". Environmental Health Perspectives. 114 (11): 1730–1735. doi:10.1289/ehp.9067. PMC   1665421 . PMID   17107860.
  48. ↑ RÍsovÁ V (September 2019). "The pathway of lead through the mother's body to the child". Interdisciplinary Toxicology. 12 (1): 1–6. doi:10.2478/intox-2019-0001. PMC   7061448 . PMID   32189981.
  49. ↑ Hu H, Téllez-Rojo MM, Bellinger D, Smith D, Ettinger AS, Lamadrid-Figueroa H, et al. (November 2006). "Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development". Environmental Health Perspectives. 114 (11): 1730–1735. doi:10.1289/ehp.9067. PMC   1665421 . PMID   17107860.
  50. ↑ Cory-Slechta DA, Virgolini MB, Thiruchelvam M, Weston DD, Bauter MR (May 2004). "Maternal stress modulates the effects of developmental lead exposure". Environmental Health Perspectives. 112 (6): 717–730. doi:10.1289/ehp.6481. PMC   1241967 . PMID   15121516.
  51. ↑ "Flint Water Tied to Fetal Death and Lower Fertility Rates". www.pbs.org. 22 September 2017. Retrieved 24 March 2024.
  52. ↑ Molnar, R. E., 2001, Theropod paleopathology: a literature survey: In: Mesozoic Vertebrate Life, edited by Tanke, D. H., and Carpenter, K., Indiana University Press, p. 337-363.
  53. ↑ Ji Q, Wu XC, Cheng YN (April 2010). "Cretaceous choristoderan reptiles gave birth to live young". Die Naturwissenschaften. 97 (4): 423–428. Bibcode:2010NW.....97..423J. doi:10.1007/s00114-010-0654-2. PMID   20179895. S2CID   8719805.
  54. ↑ Vargesson N (June 2015). "Thalidomide-induced teratogenesis: history and mechanisms". Birth Defects Research. Part C, Embryo Today. 105 (2): 140–156. doi: 10.1002/bdrc.21096 . PMC   4737249 . PMID   26043938.
  55. ↑ Knobloch J, Shaughnessy JD, Rüther U (May 2007). "Thalidomide induces limb deformities by perturbing the Bmp/Dkk1/Wnt signaling pathway". FASEB Journal. 21 (7): 1410–1421. doi: 10.1096/fj.06-7603com . PMID   17283219. S2CID   13467186.
  56. 1 2 3 4 5 6 7 Yashiro K, Zhao X, Uehara M, Yamashita K, Nishijima M, Nishino J, et al. (March 2004). "Regulation of retinoic acid distribution is required for proximodistal patterning and outgrowth of the developing mouse limb". Developmental Cell. 6 (3): 411–422. doi: 10.1016/S1534-5807(04)00062-0 . PMID   15030763.
  57. ↑ Mousa AM, Al-Fadhli AS, Rao MS, Kilarkaje N (January 2015). "Gestational lead exposure induces developmental abnormalities and up-regulates apoptosis of fetal cerebellar cells in rats". Drug and Chemical Toxicology. 38 (1): 73–83. doi:10.3109/01480545.2014.907578. PMID   24724870.
  58. ↑ Glover BJ (2014). "Historical interpretations of flower induction and flower development". Understanding flowers and flowering : an integrated approach (Second ed.). Oxford: Oxford University Press. ISBN   978-0-19-966159-6.
  59. ↑ Vázquez FM (October 2014). Turland NJ, Wiersema JH (eds.). "(023–024) Proposals to add a new Article and some Examples under Article 5". Taxon. 63 (5): 1142. doi:10.12705/635.21. ISSN   0040-0262. OCLC   6896520971. S2CID   87400780.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.